Analyst Report: Upgrade for access ActivArmor Is Making the Future of Orthopedic Casts
ActivArmor’s 3D printed casts are far superior to traditional plaster casts. And its resilient CEO has a solid growth strategy.
- Company: ActivArmor on StartEngine 2022
- Security Type: Equity - Common
- Valuation: $21,868,919
- Min Investment: $170
- Platform: StartEngine
- Deadline: Nov 3, 2022
I love companies that make me think, “Why didn’t I think of that?” These are almost never pure technology plays because the technology is already there. It’s merely waiting for a clever company with a clever idea to make profitable use of it.
The technology-in-waiting here is 3D printing (also known as “additive manufacturing”). ActivArmor is not making any extraordinary demands of 3D printing technology. It’s not asking it to make houses… artificial organs… or wagyu beef. It’s simply asking for hard plastic casts (the kind you use for broken bones or injuries).
But these hard plastic casts are better than traditional plaster casts in every way imaginable. They are…
- Available on demand
- Custom designed and fitted
- Lockable (or not)
- Latex free
One of ActivArmor’s casts being 3D printed
That’s not all. Physicians can choose whether the cast should be loose or tightly fitted. Doctors can order them in locked or removable form. Even when locked, it’s easy for the doctor to remove them during the healing process for examination or at the end of the healing process.
Patients easily 3D-map their injured limb through ActivArmor’s app on an iPhone. Within three to four days, ActivArmor delivers the cast to them (or their doctor) for fitting. The cast is tailored to their exact fit. It’s super comfortable and versatile. Patients can shower or swim with them and easily put them on or remove them (if unlocked).
ActivArmor originally manufactured these casts in a central location and delivered them to clinics within three to four days of the request. In a move to make scaling easier while improving the customer experience, ActivArmor will be providing its 3D printing hardware and software directly to clinics. As soon as the first quarter of next year, patients at these clinics will have to wait mere minutes to receive their casts.
This article requires: Edge Pro
Full site access including KingsCrowd's qualitative analyst reports.
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Startup Portfolio Tracking
- Company Search Table
- Founder Profiles
- Trending Companies
- Fundraising Analytics
- News and Crowdopedia
Company Search table full access, except for Analyst Reports.
Charts and trends of capital raised by platform, security type, industry, and more.
Unlimited Top Deal, Deal to Watch, Neutral, and Underweight reports.
Unlock "Analyst Report" filters in the Company Search table.